Evidence map›Paper›PMID 41787661›Full record

ArticleAdvanced healthcare materials2026

Common Signatures of Altered Gene Regulation and Invasiveness of Different Breast Cancer Cell Lines after Matrix Interface Crossing.

Cornelia Clemens, Hannah Trampert, Nataliia Kotsiuba, Tilo Pompe

Abstract read
In one paragraph

Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Cornelia ClemensInstitute of Biochemistry, Leipzig University, Leipzig, Germany.ORCID https://orcid.org/0009-0009-1089-1744
Hannah TrampertInstitute of Biochemistry, Leipzig University, Leipzig, Germany.
Nataliia KotsiubaInstitute of Biochemistry, Leipzig University, Leipzig, Germany.
Tilo PompeInstitute of Biochemistry, Leipzig University, Leipzig, Germany.ORCID https://orcid.org/0000-0003-1508-4959

Funding

Deutsche Forschungsgemeinschaft INST 268/293-1 FUGGDeutsche Krebshilfe 70113998DNA Core Technology Unit of Leipzig UniversityEFREFreistaat Sachsen 100144684
6 · The paper itself

Abstract

Interfaces between dense tumor tissue and surrounding more porous healthy tissue have been shown to trigger aggressive phenotypes in transmigrating MDA-MB-231 breast cancer cells, promoting directional migration, proliferation, and chemoresistance. Here, we show that such interface-instructed phenotype switching represents a common feature across triple-negative breast cancer (TNBC) cell lines, highlighting the potential for targeting these matrix interfaces in therapeutic approaches. Using a biomimetic collagen I interface model, we compared the different breast cancer cell lines, namely, MDA-MB-231, SUM159PT, and Hs578T, during the transmigration process. The interface-induced trigger of invasiveness was more pronounced in MDA-MB-231 and SUM159PT cells. RNA sequencing revealed shared transcriptional response in all three cell lines, with 228 commonly regulated genes and enrichment of pathways linked to cell cycle, chromatin organization, and DNA repair. Differences in pathway activation reflected the baseline characteristics of the three cell lines. Together, the results demonstrate that the topological and mechanical stimuli of tissue interfaces in general induce transcriptional reprogramming in TNBC cells with features of higher aggressiveness.

Indexed as

Breast NeoplasmsExtracellular MatrixGene Expression Regulation, NeoplasticTriple Negative Breast NeoplasmsCell Line, TumorCell MovementCell ProliferationFemaleHumansMDA-MB-231 CellsNeoplasm Invasivenesscell migrationextracellular matrix interfacesinvasivenessphenotype switchingtranscriptomic reprogrammingtriple‐negative breast cancer

Identifiers

PMID41787661
PMCPMC13176507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.